¼¼°èÀÇ Áø´Ü¿ë ¹æ»ç¼ºµ¿À§¿ø¼Ò ½ÃÀå º¸°í¼­(2025³â)
Diagnostic Radioisotopes Global Market Report 2025
»óǰÄÚµå : 1704114
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,371,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,209,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,048,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Áø´Ü¿ë ¹æ»ç¼ºµ¿À§¿ø¼Ò ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â ¿¬Æò±Õ 9.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 88¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº »õ·Î¿î ¹æ»ç¼ºµ¿À§¿ø¼Ò Á¦Á¶¹ý, ÀÓ»ó Àû¿ë È®´ë, ȯÀÚ Áß½É Ä¡·á ¹× ¾ÈÀü, ÇöÀå Áø·á ¿µ»ó Áø´Ü, ȯ°æ Áö¼Ó°¡´É¼º ¹× ±×¸° Äɹ̽ºÆ®¸®¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÇÏÀ̺긮µå À̹Ì¡ ±â¼ú, ¼¼¶ó¹Í, ºÐÀÚ À̹Ì¡ ±â¼ú, »çÀÌŬ·ÎÆ®·Ð ¶Ç´Â Á¦³Ê·¹ÀÌÅÍ »ç¿ë, ¾ÈÀü ¹× ¹æ»ç¼± º¸È£ µîÀÌ ÀÖ½À´Ï´Ù.

¾Ï¿¡ ´ëÇÑ ºÎ´ã Áõ°¡°¡ Áø´Ü¿ë ¹æ»ç¼ºµ¿À§¿ø¼Ò ½ÃÀå È®´ë¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾ÏÀº ÁÖº¯ Á¶Á÷À» ¼Õ»ó½ÃŰ´Â ºñÁ¤»óÀûÀÎ ¼¼Æ÷ÀÇ ¹«Áú¼­ÇÑ ºÐ¿­À» Ư¡À¸·Î ÇÏ´Â Áúº´ÀÔ´Ï´Ù. ¾ÏÀÇ À¯º´·ü Áõ°¡´Â Èí¿¬, ºñ¸¸, ¿îµ¿ ºÎÁ·°ú °°Àº »ýȰ½À°ü ¼±ÅÃ, ¹ß¾Ï¹°Áú ³ëÃâ, À¯ÀüÀû ¿äÀÎ, ȯ°æÀû ¿µÇâ µî ´Ù¾çÇÑ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¹æ»ç¼ºµ¿À§¿ø¼Ò´Â Á¤È®ÇÑ Áø´ÜÀ» Á¦°øÇϰí, Ç¥Àû Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϸç, ¾ÏÀÇ ÁøÇà°ú Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀÀ» È¿°úÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â °ÍÀ» ¿ëÀÌÇÏ°Ô ÇÔÀ¸·Î½á ¾Ï °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 5¿ù ¹Ì±¹ ±¹¸³¾Ï¿¬±¸¼Ò(National Cancer Institute)´Â 2040³â±îÁö Àü ¼¼°è ¿¬°£ ½Å±Ô ¾Ï ȯÀÚ ¼ö°¡ 2,990¸¸ ¸í¿¡ ´ÞÇÏ°í ¾ÏÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö°¡ 1,530¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¾Ï ºÎ´ã Áõ°¡°¡ Áø´Ü¿ë ¹æ»ç¼ºµ¿À§¿ø¼Ò ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Áø´Ü¿ë ¹æ»ç¼ºµ¿À§¿ø¼Ò ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Áø´Ü Á¤È®µµ Çâ»ó, ȯÀÚ °á°ú °³¼±, ÇコÄɾ¼­ ÇÙÀÇÇÐÀÇ Àû¿ë È®´ë¸¦ À§ÇØ ¹æ»ç¼º ÀǾàǰ ±â¼úÀÇ ¹ßÀü¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÷´Ü ¹æ»ç¼º ÀǾàǰ ±â¼ú¿¡´Â ÇÙÀÇÇп¡¼­ Á¤È®ÇÑ À̹Ì¡°ú Ç¥Àû Ä¡·á¸¦ À§ÇÑ Çõ½ÅÀûÀÎ È­ÇÕ¹° ¹× ±â¼ú °³¹ßÀÌ Æ÷ÇԵ˴ϴÙ. ¿¹¸¦ µé¾î ÀÌÅ»¸®¾ÆÀÇ ¿µ»ó Áø´Ü ȸ»çÀÎ ºê¶óÄÚ ±×·ìÀº 2022³â 3¿ù Â÷¼¼´ë Ä¡·á¿ë ¹æ»ç¼º ÀǾàǰ ±â¼ú °³¹ßÀ» Àü¹®À¸·Î ÇÏ´Â ÀÚȸ»ç ºí·ç¾î½º Å×¶óǻƽ½º(Blue Earth Therapeutics)¸¦ ¼³¸³Çϰí, Ãʱ⿡´Â Àü¸³¼±¾ÏÀ» Ÿ°ÙÀ¸·Î ÇÏ°í ´Ù¸¥ ¾Ï ºÐ¾ß·Î È®´ëÇÒ °èȹÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Covid ¹× °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Diagnostic radioisotopes are radioactive isotopes employed in nuclear medicine for diagnosing and monitoring diverse medical conditions. They rely on their radioactive decay characteristics to emit radiation, detected by specialized imaging tools, enabling healthcare providers to acquire detailed internal body structure images and evaluate their function.

The primary diagnostic radioisotopes include technetium-99m, thallium-201, gallium-67, iodine-123, fluorodeoxyglucose (FDG), rubidium-82, and others. Technetium-99m is extensively used in medical imaging due to its advantageous nuclear properties and wide accessibility. Imaging techniques include single photon emission computed tomography (SPECT), positron emission tomography (PET), and beta emitters, employed across various fields such as oncology and cardiology.

The diagnostic radioisotopes research report is one of a series of new reports from The Business Research Company that provides diagnostic radioisotopes market statistics, including the diagnostic radioisotopes industry's global market size, regional shares, competitors with a diagnostic radioisotopes market share, detailed diagnostic radioisotopes market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic radioisotopes industry. This diagnostic radioisotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostic radioisotopes market size has grown rapidly in recent years. It will grow from $5.54 billion in 2024 to $6.1 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to the discovery of radioactivity, the introduction of technetium-99m, clinical applications and research, cold war era and nuclear research, and emergence of positron emission tomography.

The diagnostic radioisotopes market size is expected to see strong growth in the next few years. It will grow to $8.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emerging radioisotope production methods, expanded clinical applications, patient-centered care and safety, point-of-care imaging and environmental sustainability and green chemistry. Major trends in the forecast period include hybrid imaging techniques, theranostics, molecular imaging techniques, the use of cyclotrons or generators, and safety and radiation protection.

The growing burden of cancer is expected to drive the expansion of the diagnostic radioisotopes market. Cancer is a disease characterized by the uncontrolled division of abnormal cells that damage surrounding tissue. The increasing prevalence of cancer is attributed to various factors, including lifestyle choices such as smoking, obesity, lack of physical activity, exposure to carcinogens, genetic factors, and environmental influences. Radioisotopes play a crucial role in cancer management by providing accurate diagnosis, enabling targeted treatments, and facilitating effective monitoring of cancer progression or response to therapy. For example, in May 2024, the National Cancer Institute, a US-based government agency focused on cancer research and training, projected that by 2040, the global number of new cancer cases per year will reach 29.9 million, with 15.3 million cancer-related deaths. As a result, the rising burden of cancer is driving the growth of the diagnostic radioisotopes market.

Key players in the diagnostic radioisotopes market are focused on advancing radiopharmaceutical technology to enhance diagnostic accuracy, improve patient outcomes, and expand the applications of nuclear medicine in healthcare. Advanced radiopharmaceutical technology involves the development of innovative compounds and techniques for precise imaging and targeted therapy in nuclear medicine. For example, Bracco Group, an Italy-based diagnostic imaging company, launched Blue Earth Therapeutics in March 2022, a subsidiary dedicated to advancing next-generation therapeutic radiopharmaceutical technology, initially targeting prostate cancer with plans for further expansion into other oncology areas.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS to strengthen its supply chain and manufacturing capabilities. This acquisition aims to leverage ARTMS' expertise in cyclotron-based isotope production to enhance market position and meet the growing demand for diagnostic and therapeutic isotopes. ARTMS, headquartered in Canada, specializes in radioisotope technology and is a leading provider of diagnostic radioisotopes.

Major companies operating in the diagnostic radioisotopes market are Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC

North America was the largest region in the diagnostic radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic radioisotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic radioisotopes market consists of revenues earned by entities by providing services such as radiopharmacy services, imaging services, radioisotope production and supply, diagnostic procedures, and theranostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic radioisotopes market also includes sales of products including Indium-111, Xenon-133, Molybdenum-99, and Phosphorus-32. Values in this market are 'factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Radioisotopes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic radioisotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for diagnostic radioisotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diagnostic radioisotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Diagnostic Radioisotopes market Characteristics

3. Diagnostic Radioisotopes market Trends And Strategies

4. Diagnostic Radioisotopes market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Diagnostic Radioisotopes Growth Analysis And Strategic Analysis Framework

6. Diagnostic Radioisotopes market Segmentation

7. Diagnostic Radioisotopes market Regional And Country Analysis

8. Asia-Pacific Diagnostic Radioisotopes market

9. China Diagnostic Radioisotopes market

10. India Diagnostic Radioisotopes market

11. Japan Diagnostic Radioisotopes market

12. Australia Diagnostic Radioisotopes market

13. Indonesia Diagnostic Radioisotopes market

14. South Korea Diagnostic Radioisotopes market

15. Western Europe Diagnostic Radioisotopes market

16. UK Diagnostic Radioisotopes market

17. Germany Diagnostic Radioisotopes market

18. France Diagnostic Radioisotopes market

19. Italy Diagnostic Radioisotopes market

20. Spain Diagnostic Radioisotopes market

21. Eastern Europe Diagnostic Radioisotopes market

22. Russia Diagnostic Radioisotopes market

23. North America Diagnostic Radioisotopes market

24. USA Diagnostic Radioisotopes market

25. Canada Diagnostic Radioisotopes market

26. South America Diagnostic Radioisotopes market

27. Brazil Diagnostic Radioisotopes market

28. Middle East Diagnostic Radioisotopes market

29. Africa Diagnostic Radioisotopes market

30. Diagnostic Radioisotopes market Competitive Landscape And Company Profiles

31. Diagnostic Radioisotopes market Other Major And Innovative Companies

32. Global Diagnostic Radioisotopes market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostic Radioisotopes market

34. Recent Developments In The Diagnostic Radioisotopes market

35. Diagnostic Radioisotopes market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â